Godshalk Welsh Capital Management, Inc. Pfizer Inc Transaction History

Godshalk Welsh Capital Management, Inc.

$155 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $114,972 - $149,336	-4,400 Reduced 30.14%	10,200 $293,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $170,077 - $198,803	-5,300 Reduced 26.63%	14,600 $484,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $7,223 - $8,358	-200 Reduced 1.0%	19,900 $729,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $251,111 - $326,910	-6,375 Reduced 24.08%	20,100 $820,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $137,148 - $179,032	-3,285 Reduced 11.04%	26,475 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $36,408 - $44,445	832 Added 2.88%	29,760 $1.3 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $16,285 - $19,309	-350 Reduced 1.2%	28,928 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $4,132 - $6,125	100 Added 0.34%	29,278 $1.73 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $1,795 - $2,034	-50 Reduced 0.17%	29,178 $1.21 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $5,023 - $5,665	150 Added 0.52%	29,228 $1.06 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $24,265 - $30,856	725 Added 2.56%	29,078 $1.07 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $77,787 - $91,262	2,450 Added 9.46%	28,353 $1.04 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $3,012 - $3,654	100 Added 0.39%	25,903 $847,000
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $40,545 - $57,929	-1,500 Reduced 5.49%	25,803 $842,000
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $4,938 - $5,604	150 Added 0.55%	27,303 $1.07 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $9,747 - $12,639	300 Added 1.12%	27,153 $976,000
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $11,093 - $12,456	-300 Reduced 1.1%	26,853 $1.16 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $50,775 - $55,784	1,354 Added 5.25%	27,153 $1.15 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $53,704 - $61,228	1,396 Added 5.72%	25,799 $1.13 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $63,011 - $76,428	-1,828 Reduced 6.97%	24,403 $1.08 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $1,648 - $1,757	-50 Reduced 0.19%	26,231 $952,000
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $7,977 - $9,255	-250 Reduced 0.94%	26,281 $933,000
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $73,172 - $77,638	-2,200 Reduced 7.66%	26,531 $961,000
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $46,500 - $51,225	-1,500 Reduced 4.96%	28,731 $1.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,231	30,231 $1.02 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.73 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Godshalk Welsh Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Godshalk Welsh Capital Management, Inc. with notifications on news.

Account